External validation of the barcelona magnetic resonance imaging predictive model for detecting significant prostate cancer including men receiving 5-alpha reductase inhibitors - Morote, Juan; Borque-Fernando, Ángel; Esteban, Luis M.; Picola, Natàlia; Muñoz-Rodriguez, Jesús; Paesano, Nahuel; Ruiz-Plazas, Xavier; Muñoz-Rivero, Marta V.; Celma, Ana; Manuel, Gemma García-de; Miró, Berta; Abascal, José M.; et al. (World journal of urology, 2024)
Keywords: 5-alpha Reductase Inhibitors - therapeutic use; Aged; Biopsy; Humans; Magnetic Resonance Imaging; Male; Medicine; Medicine & Public Health; Middle Aged; Multiparametric Magnetic Resonance Imaging; Nephrology; Oncology; Original; Original Article; Prediction models; Predictive Value of Tests; Prostate cancer; Prostate-specific antigen; Prostatic Neoplasms - blood; Prostatic Neoplasms - diagnostic imaging; Prostatic Neoplasms - drug therapy; Prostatic Neoplasms - pathology; Retrospective Studies; Spain; Urology; Spain; 5-alpha reductase inhibitor; Validation; Significant prostate cancer; Risk calculator; Predictive model